Newtyn Partners, L.P., Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 100,000 shares at $11.90 ($1.2M) on 2023-01-12, disclosed to the SEC on 2023-01-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MACK | BUY | 2022-02-01 | $116K | — | Filing → |
| MACK | BUY | 2020-11-27 | $504K | — | Filing → |